HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-xia Chu Selected Research

Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)

3/2015A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.
4/2007[Combination therapy of thymosin alpha1 and high dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura].
12/2005[Identification of human platelet specific functional antibody and its fragments].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-xia Chu Research Topics

Disease

3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2015 - 12/2005

Drug/Important Bio-Agent (IBA)

2Inosine Triphosphate (ITP)IBA
03/2015 - 12/2005
1Rituximab (Mabthera)FDA Link
03/2015
1Thrombopoietin (c-mpl Ligand)IBA
03/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2015
1ThymalfasinIBA
04/2007
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2007
1Platelet Membrane GlycoproteinsIBA
12/2005
1Immunoglobulin G (IgG)IBA
12/2005

Therapy/Procedure

1Therapeutics
04/2007